Results 71 to 80 of about 16,685 (240)

Polymyalgia rheumatica in a married couple

open access: yesInternational Journal of General Medicine, 2012
Christoph Alexander Rüst,1 Beat Knechtle,1,2 Thomas Rosemann,1 Felix Wermelinger31Institute of General Practice and Health Services Research, University of Zurich, Zurich, Switzerland; 2St Gallen Health Center, St Gallen, Switzerland ...
Rüst CA   +3 more
doaj  

Polymyalgia rheumatica patients with and without elevated baseline acute phase reactants: distinct subgroups of polymyalgia rheumatica?

open access: yesClinical and Experimental Rheumatology, 2020
OBJECTIVES Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disease characterised by pain and stiffness of neck, shoulder- and hipgirdle, typically with elevated acute phase reactants (APR). However, patients may present with normal APR. Our aim
D. Marsman   +5 more
semanticscholar   +1 more source

Vagus Nerve Stimulation in Autoimmune Conditions: A Systematic Review

open access: yesACR Open Rheumatology, Volume 7, Issue 12, December 2025.
Objective Systemic autoimmune conditions are characterized by increased inflammation and high disease burden. Vagus nerve stimulation (VNS) is known to activate the cholinergic anti‐inflammatory pathway and can serve as a potential therapeutic modality for autoimmune conditions. This study aimed to conduct a preregistered systematic review to determine
Lina E. Lombo   +3 more
wiley   +1 more source

AB0172 ANTI-MITOFUSIN-1 AND THROMBOSPONDIN-1 AS POTENTIAL MARKERS FOR POLYMYALGIA RHEUMATICA [PDF]

open access: bronze, 2023
Linda Johansson   +3 more
openalex   +1 more source

Polymyalgia rheumatica following infective triggers or vaccinations: a different subset of disease?

open access: yesRheumatology, 2020
Objectives Polymyalgia rheumatica (PMR) is the commonest inflammatory disorder of the elderly; an association with environmental triggers and a deregulated immune response have been described.
P. Falsetti   +7 more
semanticscholar   +1 more source

Efficacy and Safety of ABBV‐154 for the Treatment of Active Rheumatoid Arthritis: A Phase 2b, Randomized, Placebo‐Controlled Trial

open access: yesArthritis &Rheumatology, Volume 77, Issue 12, Page 1673-1681, December 2025.
Objective Despite the availability of biologic and targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) to treat rheumatoid arthritis (RA), many patients do not experience optimized disease control. Glucocorticoids are effective but have safety risks.
Frank Buttgereit   +13 more
wiley   +1 more source

Cardiovascular Health, Genetic Susceptibility, and the Risk of Incident Autoimmune Disorders in the UK Biobank: A Prospective Cohort Study

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Autoimmune diseases are closely linked to cardiovascular diseases. This study aimed to assess the relationship between cardiovascular health (CVH) defined by Life's Essential 8 (LE8), genetic predisposition, and the risk of 19 autoimmune ...
Lijin Lin   +8 more
doaj   +1 more source

Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica

open access: yesAnnals of the Rheumatic Diseases, 2020
We read with great interest the article ‘Addressing immune-related adverse events of cancer immunotherapy: how prepared are rheumatologists?’ by Kostine et al .1 The introduction of immune checkpoint inhibitor (ICI) therapy has been a major breakthrough ...
K. V. D. van der Geest   +6 more
semanticscholar   +1 more source

A Rare Case of Giant Cell Arteritis Affecting Two Giants: Pulmonary and Root of Aorta Aneurysm

open access: yesClinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Aneurysms of pulmonary arteries and aorta are rare, typically caused by infections, congenital heart defects, vascular abnormalities, or medical interventions. This report presents an unusual case of a 72‐year‐old man with a history of smoking, hypertension, and emphysema, who was found to have a large pulmonary artery aneurysm (63.5 mm) and ...
Gajendra Acharya   +5 more
wiley   +1 more source

Case report of transient polymyalgia rheumatica after receiving the first dose of the BNT162b2 mRNA COVID-19 vaccine

open access: yesSAGE Open Medical Case Reports
Messenger ribonucleic acid-based vaccines that target severe acute respiratory syndrome coronavirus 2 have shown high effectiveness. While these Coronavirus Disease 2019 vaccines have a favorable safety profile, there can be rare adverse drug reactions ...
Kosuke Matsuzono, Shigeru Fujimoto
doaj   +1 more source

Home - About - Disclaimer - Privacy